F154-0273 Screening compound: 4-[(2-{[(4-chlorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]-N-[2-(1H-imidazol-4-yl)ethyl]benzamide

F154-0273 Screening compound: 4-[(2-{[(4-chlorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]-N-[2-(1H-imidazol-4-yl)ethyl]benzamide
F154-0273 Screening compound: 4-[(2-{[(4-chlorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]-N-[2-(1H-imidazol-4-yl)ethyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F154-0273
4-[(2-{[(4-chlorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]-N-[2-(1H-imidazol-4-yl)ethyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F154-0273

Molecular Formula

C26H23ClN6OS (C26 H23 ClN6 OS)

Compound Name

4-[(2-{[(4-chlorophenyl)methyl]sulfanyl}-3H-imidazo[4,5-c]pyridin-3-yl)methyl]-N-[2-(1H-imidazol-4-yl)ethyl]benzamide

IUPAC name

4-[(2-{[(4-chlorophenyl)methyl]sulfanyl}-3H-imidazo[45-c]pyridin-3-yl)methyl]-N-[2-(1H-imidazol-4-yl)ethyl]benzamide

SMILES

O=C(c1ccc(Cn2c(SCc(cc3)ccc3Cl)nc3c2cncc3)cc1)NCCc1c[nH]cn1

InChI

InChI=1S/C26H23ClN6OS/c27-21-7-3-19(4-8-21)16-35-26-32-23-10-11-28-14-24(23)33(26)15-18-1-5-20(6-2-18)25(34)30-12-9-22-13-29-17-31-22/h1-8,10-11,13-14,17H,9,12,15-16H2,(H,29,31)(H,30,34)

InChI Key

ZOJZPCPFTGINBE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27105964

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

503.03

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.900

Distribution Coefficient, logD

3.895

Water Solubility, LogSw

-4.51

Polar Surface Area

66.044

Acid Dissociation Constant (pKa)

13.31

Base Dissociation Constant (pKb)

5.41

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.40

F154-0273 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

CNS Targets (44014 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

GABA Library (7115 compounds)

Nucleic Acid Ligands (8311 compounds)

Targeted Diversity Library (40567 compounds)

Antibacterial Compounds Library (13827 compounds)

Developmental Pathway (Hh/Wnt) Set (2238 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Eye
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Proteases
  • GPCR
  • Ion Channels
  • Others
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F154-0273 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F154-0273?
Check Price and Availability of F154-0273, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F154-0273 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F154-0273
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F154-0273
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F154-0273 available by request